Amadori- 162.0528 CML-58.0055 CEL-72.0211 MGH1-54.0106 H- 1.00783 O- 15.9949.

Slides:



Advertisements
Similar presentations
Tandem MS (MS/MS) on the Q-ToF2
Advertisements

1/8 AND, OR and NOT b How many boys? b How many girls? b How many blue? b How many red?
The Build-up of the Red Sequence at z
S 3.1 Positive ionization low energy CID fragmentation spectrum of the singly phosphorylated peptide pSLKPDTENQESSVK of Rec 10 MS 3 spectrum of the doubly.
UC Mass Spectrometry Facility & Protein Characterization for Proteomics Core Proteomics Capabilities: Examples of Protein ID and Analysis of Modified Proteins.
In-depth Analysis of Protein Amino Acid Sequence and PTMs with High-resolution Mass Spectrometry Lian Yang 2 ; Baozhen Shan 1 ; Bin Ma 2 1 Bioinformatics.
Proteomics Informatics – Protein identification III: de novo sequencing (Week 6)
De Novo Sequencing and Homology Searching with De Novo Sequence Tags.
CSE182 CSE182-L12 Mass Spectrometry Peptide identification.
Protein Sequencing and Identification by Mass Spectrometry.
May 12-15, 2011 (red) May 6-11, 2011 (light red) Permanent Water (blue)
Data Processing Algorithms for Analysis of High Resolution MSMS Spectra of Peptides with Complex Patterns of Posttranslational Modifications Shenheng Guan.
PEAKS: De Novo Sequencing using MS/MS spectra Bin Ma, U. Western Ontario, Canada Kaizhong Zhang,U. Western Ontario, Canada Chengzhi Liang, Bioinformatics.
The peptide bond is the weakest point, so the protein will break into two pieces.... After collision with helium the peptide will break into characteristic.
Mass Spectrometry Peptide identification
Fa 05CSE182 CSE182-L8 Mass Spectrometry. Fa 05CSE182 Bio. quiz What is a gene? What is a transcript? What is translation? What are microarrays? What is.
De Novo Sequencing of MS Spectra
Scaffold Download free viewer:
My contact details and information about submitting samples for MS
1 Mass Spectrometry-based Proteomics Xuehua Shen (Adapted from slides with textbook)
Protein sequencing and Mass Spectrometry. Sample Preparation Enzymatic Digestion (Trypsin) + Fractionation.
Circulating Fragments of N- Terminal Pro B-Type Natriuretic Peptide in Plasma of Heart Failure Patients J.Y.Y. Foo, Y. Wan, B.L. Schulz, K. Kostner, J.
The dynamic nature of the proteome
PROTEIN STRUCTURE NAME: ANUSHA. INTRODUCTION Frederick Sanger was awarded his first Nobel Prize for determining the amino acid sequence of insulin, the.
$100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300.
INF380 - Proteomics-91 INF380 – Proteomics Chapter 9 – Identification and characterization by MS/MS The MS/MS identification problem can be formulated.
Common parameters At the beginning one need to set up the parameters.
Analysis of Complex Proteomic Datasets Using Scaffold Free Scaffold Viewer can be downloaded at:
A Comprehensive Comparison of the de novo Sequencing Accuracies of PEAKS, BioAnalyst and PLGS Bin Ma 1 ; Amanda Doherty-Kirby 1 ; Aaron Booy 2 ; Bob Olafson.
Legends For ETD data In the spectra  = precursor ions, charge-reduced ones too; * = charge-reduced ion from a coeluting precursor ion with different,
A Phospho-Peptide Spectrum Library for Improved Targeted Assays Barbara Frewen 1, Scott Peterman 1, John Sinclair 2, Claus Jorgensen 2, Amol Prakash 1,
ETD & ETD/PTR Electron Transfer Dissociation Proton Transfer Reaction
INF380 - Proteomics-101 INF380 – Proteomics Chapter 10 – Spectral Comparison Spectral comparison means that an experimental spectrum is compared to theoretical.
Structural Characterization of Bacterial Levansucrase by Matrix- assisted Laser Desorption/Ionization Mass Spectrometry Hong Liu 03/23/04.
 -amanitin CHX (h) K921 Ac-Abl Abl Additional file, Figure S4.
PEAKS: De Novo Sequencing using Tandem Mass Spectrometry Bin Ma Dept. of Computer Science University of Western Ontario.
CSE182 CSE182-L12 Mass Spectrometry Peptide identification.
Anti-Importin  3 NIH3T3 cells Primary hippocampal neurons Mouse ES cells Anti-Importin  1 Anti-Importin  1 NIH3T3 cells Primary hippocampal neurons.
CSE182 CSE182-L11 Protein sequencing and Mass Spectrometry.
Faster, more sensitive peptide identification from tandem mass spectra by sequence database compression Nathan J. Edwards Center for Bioinformatics & Computational.
Overview of Mass Spectrometry
Protein Identification Using Tandem Mass Spectrometry Nathan Edwards Center for Bioinformatics and Computational Biology University of Maryland, College.
The observed and theoretical peptide sequence information Cal.MassObserved. Mass ±da±ppmStart Sequence EndSequenceIon Score C.I%modification FLPVNEK.
Mascot Example Slides. MS/MS Database Search Example Data: BSAonespectra.mgf (one spectra) Database: bovine Fixed modifications: Carboxymethyl(C )
a) b) c) d) e)
B Monoisotopic mass of neutral peptide M r (calc): Fixed modifications: Carbamidomethyl Ions score: 45 † Expect: ‡ Matches (red): 18/50.
10/30/2013BCHB Edwards Project/Review BCHB Lecture 17.
Post translational modification n- acetylation Peptide Mass Fingerprinting (PMF) is an analytical technique for identifying unknown protein. Proteins to.
MassMatrix Search Results Explained
Volume 8, Issue 2, Pages (February 2001)
Phosphopeptide sequencing by MALDI-TOF/TOF of the C-terminal tail of AtPIP2;1.A, MS/MS spectrum of singly phosphorylated 277SLGSFRSAANV287 (m/z ).
Car Race – Linear Sequences
Extension of the GlyRβ binding site on gephyrin.
Interpretation of Mass Spectra I
Proteomic analysis of subtilisin-digested purified porcine brain tubulin. Proteomic analysis of subtilisin-digested purified porcine brain tubulin. (A)
Identification of MOSPD2, a new FFAT motif‐binding protein
Signaling by Transmembrane Proteins Shifts Gears
CD4-Induced Activation in a Soluble HIV-1 Env Trimer
Volume 22, Issue 4, Pages (October 2015)
PKA phosphorylates Thr63 and Ser692 to increase HIF-1α stability.
A, Averaged full MS (ions converted to monoisotopic MW by Xcalibur Xtract) of Segment I-3 (see supplemental Fig. A, Averaged full MS (ions converted to.
2D-LC-MS/MS analysis of tryptic digest of HEK293-SUMO3 cells (2 μg inj
Helical peptide models for protein glycation: proximity effects in catalysis of the Amadori rearrangement  Janani Venkatraman, Kamna Aggarwal, P Balaram 
Modified at -
Interpretation of Mass Spectra
The molecular network of a family of sesquiterpene lactones and the distribution of a representative molecule with an MS/MS spectrum match to alantolactone.
LC8 is structurally variable but conserved in sequence.
ASPP2 hydroxylation is detectable in vivo and the amount of hydroxylation depends on FIH-1 abundance. ASPP2 hydroxylation is detectable in vivo and the.
Identification of multiple ubiquitination sites in the LRR domain of Shoc2 by LC-MS/MS. Identification of multiple ubiquitination sites in the LRR domain.
Mass spectrometry identification of biomarker candidates in the prediagnostic plasmas in the Women's Health Initiative cohort. Mass spectrometry identification.
Presentation transcript:

Amadori CML CEL MGH H O

PLGS identified AGE modified Peptides In HSA associated with CICs from Clinical plasma (Annotated MS/MS spectra)

A.Unmodified peptide B.Modified peptide C.Highlighted modified residue with “b-ions” or “y ions” encompassing the modified site. The lines (blue line for “b-ion and red line for y-ion) show the mass shift (∆M) corresponding to the type of AGE modification. Depiction of AGE modified MS/MS spectra

CON

A7 Sequence: RDAHKSEVAHR CML (5) A. B. C. ∆M ∆M (b5) = Da Da (CML)

CASLQKFGERAFK Carbamidomethyl C (1), CEL (6) Sequence: CASLQKFGERAFK Carbamidomethyl C (1), CEL (6) A. B. C Da (CEL) ∆M ∆M (b7) = Da

Sequence: NLGKVGSKCCK AMADORI (8), Carbamidomethyl C (9), Carbamidomethyl C (10) ∆M ∆M (y4) = Da Da (AMADORI)

IGT

Da (AMADORI) Sequence: LDELRDEGKASSAK AMADORI (5) A. B. C. ∆M ∆M (y11) = Da

Sequence: AEFAEVSKLVTDLTK CML (8) Da (CML) A. B. C. ∆M1 (b8) = Da ∆M Da (CML)

Da (CEL) Da (AMADORI) Sequence: NLGKVGSKCCK CEL (4), AMADORI (8), Carbamidomethyl C (9), Carbamidomethyl C (10) A. B. C. ∆M1 ∆M1 (y8) = Da ∆M2 ∆M2 (y4) = Da

NDD

Sequence: CASLQKFGERAFK Carbamidomethyl C (1), CEL (6) A. B. C Da (CEL) ∆M ∆M (y10) = Da

LSQRFPKAEFAEVSK MGH1 (4) ∆M ∆M (b5) = Da Da (MGH1)

Sequence: AEFAEVSKLVTDLTK CML (8) Da (CML) ∆M ∆M (b8) = Da A. B. C.

Sequence: DVFLGMFLYEYARR AMADORI (13) Da (AMADORI) ∆M ∆M (y2) = Da A. B. C.

Sequence: KQTALVELVK AMADORI (1) Da (AMADORI) ∆M ∆M (b1) = Da A. B. C.

DM

Sequence: RDAHKSEVAHR AMADORI (1), AMADORI (5) Da (AMADORI) ∆M1 ∆M1 (b2) = Da ∆M2 ∆M2 (b5) = Da A. B. C Da (AMADORI)

Da (CML) Sequence: ASSAKQRLK CML (5) ∆M ∆M (y5) = Da A. B. C.

Da (CEL) Sequence: CASLQKFGERAFK Carbamidomethyl C (1), CEL (6) A. B. C. ∆M ∆M (b7) = Da

Da (CML) Sequence: AEFAEVSKLVTDLTK CML (8) ∆M ∆M (b8) = Da A. B. C.

DM-MIC

F Da (CML) RDAHKSEVAHR CML (5) ∆M ∆M (y7) = Da A. B. C.

Sequence: AACLLPKLDELR Carbamidomethyl C (3), AMADORI (7) Da (AMADORI) ∆M ∆M (b7) = Da A. B. C.

Sequence: AEFAEVSKLVTDLTK CML (8) ∆M ∆M (b8) = Da A. B Da (CML) C Da (CML)

Da (CEL) Sequence: LKECCEKPLLEK Carbamidomethyl C (4), Carbamidomethyl C (5), CEL (7) ∆M ∆M (y6) = Da A. B. C.